SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMY (bristol myers squibb) -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (189)10/22/2019 10:22:41 AM
From: Miljenko Zuanic  Respond to of 194
 
I did not re-enter BMY (no ammunition), but...
<The end of the keytruda magic>???
CheckMate -9LA, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Combined with Chemotherapy, Meets Primary Endpoint Demonstrating Superior Overall Survival Compared to Chemotherapy Alone in First-Line Lung Cancer
finance.yahoo.com